Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVBP

ArriVent BioPharma Inc

May 29 • 04:00PM ET

30.27

+3.30 12.24 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR NUVL BMRN RYTM INCY KRYS VKTX AXSM MDGL NBIX

| Held by: VTI XBI IWM VXF IWO IBB VTWO SCHA IWC VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.53	Insider Own	34.32%	Shs Outstand	45.31M	Perf Week	12.11%
Market Cap	1.41B	Forward P/E	-	EPS next Y	-3.42	Insider Trans	-3.36%	Shs Float	32.66M	Perf Month	0.73%
Enterprise Value	1.08B	PEG	-	EPS next Q	-0.97	Inst Own	70.01%	Short Float	22.35%	Perf Quarter	31.78%
Income	-145.24M	P/S	-	EPS this Y	7.36%	Inst Trans	3.36%	Short Ratio	14.14	Perf Half Y	32.88%
Sales	0.00M	P/B	4.23	EPS next Y	14.47%	ROA	-51.43%	Short Interest	7.30M	Perf YTD	50.45%
Book/sh	7.15	P/C	4.32	EPS next 5Y	31.75%	ROE	-55.17%	52W High	32.14 -5.82%	Perf Year	44.14%
Cash/sh	7.01	P/FCF	-	EPS past 3/5Y	-57.73% -29.43%	ROIC	-44.79%	52W Low	16.10 88.01%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.56% 5.84%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	6.28%	Oper. Margin	-	ATR (14)	1.62	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	13.95	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	60.73	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	13.95	EPS Q/Q	49.18%	SMA20	6.55%	Beta	1.42	Target Price	43.92
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	10.98%	Rel Volume	2.56	Prev Close	26.97
Employees	77	LT Debt/Eq	0.00	Earnings	May 11 AMC	SMA200	33.97%	Avg Volume	516.22K	Price	30.27
IPO	Jan 26, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	-7.24% -	Trades		Volume	1,309,800	Change	12.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)